Cariprazine

4 FDA-DMF suppliersSmall Molecule

Overview

Cariprazine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2028019).

API suppliers (4)

Suppliers of Cariprazine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • APITORIA PHARMA PRIVATE LTDIndia1 active DMF
  • MAPRIMED SAArgentina1 active DMF
  • MEHTA API Pvt. Ltd.India1 active DMF
  • Taiji Biopharmaceuticals Pvt. Ltd.India1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (6 approved US products), the latest listed US patent on Cariprazine expires 17 Mar 2030 and exclusivity 18 Jun 2029. Generic API sourcing typically opens up once these lapse.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo